Principal Global Investors Files Collegium Pharmaceutical Schedule 13G/A
A Schedule 13G/A for Collegium Pharmaceutical was filed by Principal Global Investors.
Related stories
Australian Energy Stocks Reach One-Week High as Oil Rises
Australian energy stocks reached a one-week high as supply concerns lifted oil prices.
M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC
Nasdaq 100 futures fall 2%; S&P 500 futures down almost 1%
M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC
U.S. Stock Futures Fall as Intel and Amazon Earnings Weigh
At 11:44 p.m. EDT, Dow futures fell 0.17%, S&P 500 futures fell 0.95% and Nasdaq-100 futures fell more than 2% after disappointing earnings from Intel and Amazon.
M impact | EQUITY | Oct 30, 2026, 04:03 AM UTC
Janome to Buy Back Up to 5.98% of Shares
L impact | EQUITY | Oct 30, 2026, 04:02 AM UTC
Asian session market picture: S&P 500 -0.94%, Nasdaq 100 -2.06%; USD/JPY -0.15%, WTI +1.18%, 1810 leads volume
Asian session market picture. US index futures: S and P futures is down 0.94 percent, Nasdaq futures is down 2.06 percent, Dow futures is down 0.19 percent and Russell futures is d
M impact | EQUITY | Oct 30, 2026, 04:00 AM UTC
Hengsheng Real Estate Delisted on Nov. 3
Hengsheng Real Estate’s listing status was formally revoked on Nov. 3.
L impact | EQUITY | Oct 30, 2026, 03:59 AM UTC